Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: CYRED EQ — Supplemental Application (Afaxys Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for CYRED EQ (desogestrel and ethinyl estradiol) from Afaxys Pharma, LLC. The product is a combined oral contracepti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYRED EQ (Desogestrel and Ethinyl Estradiol)

Snippet

SUPPL AP for CYRED EQ (DESOGESTREL AND ETHINYL ESTRADIOL)